✦ LIBER ✦

Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

✍ Scribed by Aman U. Buzdar; Marsha D. McNeese; Gabriel N. Hortobagyi; Terry L. Smith; Shu Kau; Giuseppe Fraschini; Verena Hug; Nancy Ellerbroek; Frankie A. Holmes; Frederick Ames; S. Eva Singletary

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 548 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900201)65:3<394::aid-cncr2820650303>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant systemic chemotherapy and hormo

Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient

✍ Bruce G. Haffty; Linda Wilmarth; Lynn Wilson; Diana Fischer; Malcolm Beinfield; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

Relative effect of steroid hormone recep

Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the study group for the Japanese breast cancer society on hormone receptors and prognosis in breast cancer

✍ Yasuo Nomura; Shigeto Miura; Hiroki Koyama; Kohji Enomoto; Fujio Kasumi; Hiroshi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 886 KB

Effect of the method of biopsy on the pr

Effect of the method of biopsy on the prognosis of and reliability of receptor assays in patients with operable breast cancer

✍ Mr I. S. Fentiman; R. R. Millis; M. A. Chaudary; R. J. B. King; K. J. Miller; J. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB 👁 2 views

Longitudinal study of the assessment by

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

✍ Uma Sharma; Karikanni Kalathil A. Danishad; Vurthaluru Seenu; Naranamangalam R. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

P53 is the strongest predictor of surviv

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen